Navelbine: Clinical Trials

18 trials of Navelbine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 6 terminated, 1 recruiting, 1 unknown. 18 Phase 1, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 118Completed 10, Terminated 6, Recruiting 1, Unknown 1
Phase 27Terminated 5, Completed 1, Recruiting 1

Follow Navelbine: new trials by email Literature Review of Navelbine trials Research Report on Navelbine

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
Vinorelbine, Trastuzumab Emtansine - Breast Cancer, Metastatic Breast Cancer
Phase 1 / Phase 2TerminatedUniversity of Miami22017-04-122019-04-17
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
Ribociclib, Topotecan, Temozolomide - Pediatric Cancer
Phase 1 / Phase 2RecruitingGustave Roussy, Cancer Campus, Grand Paris4722016-08-032026-07-10
the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs
JinFuKang, Cisplatin, Pemetrexed - Non-small Cell Lung Cancer(NSCLC)
Phase 1CompletedShanghai University of Traditional Chinese Medicine2182015-06-012019-09-20
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
Pembrolizumab, Gemcitabine, Docetaxel - Advanced Cancer, Breast Cancer
Phase 1 / Phase 2TerminatedWestern Regional Medical Center812014-12-012018-07-02
Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma
panobinostat, Ifosfamide, Gemcitabine - Hodgkin's Lymphoma
Phase 1UnknownArmando Santoro, MD242011-07-012014-01-29
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Pazopanib, Vinorelbine - Metastatic Non Small Cell Lung Cancer, Metastatic Breast Cancer
Phase 1TerminatedNorthwestern University82010-02-012013-10-30
Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer
Vinorelbine (Navelbine), Erlotinib - Non-Small Cell Lung Cancer
Phase 1CompletedNational Cancer Centre, Singapore302008-04-012012-10-19
Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer
Lapatinib, vinorelbine - Breast Cancer
Phase 1CompletedUNICANCER332007-06-012014-01-14
Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
ibritumomab tiuxetan, rituximab, melphalan - Lymphoma
Phase 1CompletedSwiss Cancer Institute202006-10-012019-05-15
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
CIK cells, etoposide, bcnu - Leukemia, Multiple Myeloma
Phase 1CompletedSally Arai222006-05-012017-01-11
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
lapatinib ditosylate, vinorelbine ditartrate, comparative genomic hybridization - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedUniversity of California, Davis222005-12-012012-04-19
A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer
ABI-007, vinorelbine, Trastuzumab - Stage IV (Metastatic) Breast Cancer
Phase 1 / Phase 2TerminatedCelgene162005-08-012019-11-26
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
Navelbine, Capecitabine - Breast Cancer
Phase 1CompletedDana-Farber Cancer Institute402002-03-012013-02-07
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Paclitaxel, Vinorelbine, Herceptin - Breast Cancer
Phase 1 / Phase 2TerminatedUniversity of Washington382001-03-012017-07-17
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
Carboplatin, Capecitabine, Vinorelbine - Breast, Cancer
Phase 1 / Phase 2CompletedUniversity of New Mexico332000-05-012010-01-07
Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer
trastuzumab, vinorelbine ditartrate - Breast Cancer
Phase 1CompletedDartmouth-Hitchcock Medical Center131999-11-012013-03-14
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
carboplatin, Gemcitabine, paclitaxel - Lung Cancer
Phase 1 / Phase 2TerminatedNorthwestern University361999-08-012012-06-06
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer
Paclitaxel, Vinorelbine, Filgrastim - Breast Cancer
Phase 1CompletedUniversity of Chicago261999-06-012014-03-07

Conditions studied

Breast Neoplasms (9)  ·  Carcinoma, Non-Small-Cell Lung (4)  ·  Lung Neoplasms (3)  ·  Lymphoma (2)  ·  Neoplasms (2)  ·  Burkitt Lymphoma (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Immunoblastic (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)

Sponsors

Northwestern University (2)  ·  Armando Santoro, MD (1)  ·  Celgene (1)  ·  Dana-Farber Cancer Institute (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  National Cancer Centre, Singapore (1)  ·  Sally Arai (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  Swiss Cancer Institute (1)  ·  UNICANCER (1)  ·  University of California, Davis (1)  ·  University of Chicago (1)  ·  University of Miami (1)  ·  University of New Mexico (1)

Countries

United States (12)  ·  France (2)  ·  Italy (2)  ·  Denmark (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Angelika Bischof Delaloye, Prof (1)  ·  Armando Santoro, MD (1)  ·  Ashish Sangal, MD (1)  ·  Birgit Geoerger, MD (1)  ·  Craig A. Bunnell, MD (1)  ·  Gregory A. Masters, MD (1)  ·  Helen K. Chew, MD (1)  ·  Ian Rabinowitz, MD (1)  ·  Julie R. Gralow, M.D. (1)  ·  Jyoti D Patel, MD (1)  ·  Michele Ghielmini, Prof (1)  ·  Michele Voegeli, MD (1)  ·  Peter A. Kaufman, MD (1)  ·  Pierre Fumoleau, MD, PhD (1)  ·  Reshma Mahtani, DO (1)

Results publications

PMID 15246197, PMID 27135612, PMID 27677906, PMID 29119276, PMID 31538815, PMID 33892407, PMID 34347542, PMID 34543871, PMID 35292802, PMID 41838385, PMID 42686334

NIH funding

2005 (1), 2016 (1), P30CA023108 (1), P30CA093373 (1)